“Combination” Lyme Disease Vaccine Proteins Patented by Brookhaven National Laboratory

UPTON, NY -- Scientists at the U.S. Department of Energy’s Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or “combination,” proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.>>> Discuss This Story

MORE ON THIS TOPIC